Oxidase uncoupling in heme monooxygenases: Human cytochrome P450 CYP3A4 in Nanodiscs

被引:47
|
作者
Grinkova, Yelena V.
Denisov, Ilia G.
McLean, Mark A.
Sligar, Stephen G.
机构
[1] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA
[2] Univ Illinois, Dept Chem, Urbana, IL 61801 USA
关键词
Cytochrome P450; CYP3A4; Nanodiscs; P450; mechanism; Uncoupling; Oxidase pathway; LIVER MICROSOMAL CYTOCHROME-P-450; HIGH-VALENT IRON; OXYGEN ACTIVATION; LIGAND-BINDING; 3A4; COOPERATIVITY; KINETICS; HYDROXYLATION; INTERMEDIATE; OXIDATIONS;
D O I
10.1016/j.bbrc.2012.12.072
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The normal reaction mechanism of cytochrome P450 operates by utilizing two reducing,equivalents to reduce atmospheric dioxygen, producing one molecule of water and an oxygenated product in an overall stoichiometry of 2 electrons:1 dioxygen:1 product. However, three alternate unproductive pathways exist where the intermediate iron-oxygen states in the catalytic cycle can yield reduced oxygen products without substrate metabolism. The first involves release of superoxide from the oxygenated intermediate while the second occurs after input of the second reducing equivalent. Superoxide rapidly dismutates and hence both processes produce hydrogen peroxide that can be cytotoxic to the organism. In both cases, the formation of hydrogen peroxide involves the same overall stoichiometry as oxygenases catalysis. The key step in the catalytic cycle of cytochrome P450 involves scission of the oxygen-oxygen bond of atmospheric dioxygen to produce a higher valent iron-oxo state termed "Compound I". This intermediate initiates a radical reaction in the oxygenase pathway but also can uptake two additional reducing equivalents from reduced pyridine nucleotide (NADPH) and the flavoprotein reductase to produce a second molecule of water. This non-productive decay of Compound I thus yields an overall oxygen to NADPH ratio of 1:2 and does not produce hydrocarbon oxidation. This water uncoupling reaction provides one of a limited means to study the reactivity of the critical Compound I intermediate in P450 catalysis. We measured simultaneously the rates of NADPH and oxygen consumption as a function of substrate concentration during the steady-state hydroxylation of testosterone catalyzed by human P450 CYP3A4 reconstituted in Nanodiscs. We discovered that the "oxidase" uncoupling pathway is also operating in the substrate free form of the enzyme with rate of this pathway substantially increasing with the first substrate binding event. Surprisingly, a large fraction of the reducing equivalents used by the P450 system is wasted in this oxidase pathway. In addition, the overall coupling with testosterone and bromocryptine as substrates is significantly higher in the presence of anionic lipids, which is attributed to the changes in the redox potential of CYP3A4 and reductase. (C) 2012 Elsevier Inc. All rights reserved.
引用
收藏
页码:1223 / 1227
页数:5
相关论文
共 50 条
  • [31] Cytochrome b5 Is a Major Determinant of Human Cytochrome P450 CYP2D6 and CYP3A4 Activity In Vivo
    Henderson, Colin J.
    McLaughlin, Lesley A.
    Scheer, Nico
    Stanley, Lesley A.
    Wolf, C. Roland
    MOLECULAR PHARMACOLOGY, 2015, 87 (04) : 733 - 739
  • [32] Chloramphenicol is a potent inhibitor of cytochrome P450 isoforms CYP2C19 and CYP3A4 in human liver microsomes
    Park, JY
    Kim, KA
    Kim, SL
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (11) : 3464 - 3469
  • [33] Retraction Note to: Identification of CYP3A4 as the primary cytochrome P450 responsible for the metabolism of tandospirone by human liver microsomes
    Kiyohi Natsui
    Yoshiko Mizuno
    Naoko Tani
    Masashi Yabuki
    Setsuko Komuro
    European Journal of Drug Metabolism and Pharmacokinetics, 2019, 44 : 853 - 853
  • [34] RETRACTED ARTICLE: Identification of CYP3A4 as the primary cytochrome P450 responsible for the metabolism of tandospirone by human liver microsomes
    Kiyohi Natsui
    Yoshiko Mizuno
    Naoko Tani
    Masashi Yabuki
    Setsuko Komuro
    European Journal of Drug Metabolism and Pharmacokinetics, 2007, 32 : 131 - 137
  • [35] A Minimal Functional Complex of Cytochrome P450 and FBD of Cytochrome P450 Reductase in Nanodiscs
    Prade, Elke
    Mahajan, Mukesh
    Im, Sang-Choul
    Zhang, Meng
    Gentry, Katherine A.
    Anantharamaiah, G. M.
    Waskell, Lucy
    Ramamoorthy, Ayyalusamy
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2018, 57 (28) : 8458 - 8462
  • [36] Endocannabinoid metabolism by cytochrome P450 monooxygenases
    Zelasko, Susan
    Arnold, William R.
    Das, Aditi
    PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2015, 116 : 112 - 123
  • [37] Cytochrome P450 monooxygenases metabolizing herbicides
    Ohkawa, H
    Shiota, N
    Imaishi, H
    Yamada, T
    Inui, H
    Ohkawa, Y
    BIOTECHNOLOGY & BIOTECHNOLOGICAL EQUIPMENT, 1998, 12 (02) : 17 - 22
  • [38] Coexpression of a human P450 (CYP3A4) and P450 reductase generates a highly functional monooxygenase system in Escherichia coli
    Blake, JAR
    Pritchard, M
    Ding, SH
    Smith, GCM
    Burchell, B
    Wolf, CR
    Friedberg, T
    FEBS LETTERS, 1996, 397 (2-3) : 210 - 214
  • [39] A Measurement Method for Cytochrome P450 3A4 (CYP3A4)-mediated Oxidation of Cholesterol in Lipid Membranes
    Shoji, Atsushi
    Miki, Haruka
    Kikkawa, Mikiko
    Yamamoto, Miyu
    Moriiwa, Yukiko
    Morioka, Kazuhiro
    Yanagida, Akio
    SENSORS AND MATERIALS, 2022, 34 (03) : 951 - 960
  • [40] Membrane Anchor of Cytochrome P450 Reductase Suppresses the Uncoupling of Cytochrome P450
    Miyamoto, Masayoshi
    Yamashita, Taku
    Yasuhara, Yuki
    Hayasaki, Akinori
    Hosokawa, Yukari
    Tsujino, Hirofumi
    Uno, Tadayuki
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2015, 63 (04) : 286 - 294